SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Rigel Pharmaceuticals is currently trending as investors focus on the anticipated mid-year commercial launch of Veppanu, the first FDA-approved PROTAC therapy, which the community views as a potential blockbuster asset. Despite strong fundamentals and profitability, the stock is seeing high volatility and significant short interest, leading to intense debate among retail investors about the potential for a short squeeze or strategic acquisition.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean (RIG) is trending as the market reacts to shifting geopolitical tensions in the Strait of Hormuz, with investors closely watching for the upcoming Valaris acquisition and potential earnings catalysts. The community is actively debating the stock's long-term potential as a beneficiary of offshore drilling demand versus short-term price volatility fueled by ongoing energy sector speculation.

Silicon Motion Technology Corp. engages in the development, manufacture, and supply of semiconductor products for the electronics market. The firm’s products include Flash Controllers, Storage Solutions, and others. It offers embedded and expandable storage, radio frequency integrated circuits, and embedded graphics. The company was founded by Wallace C. Kou in November 1995 and is headquartered in Hong Kong.

Silicon Motion Technology Corp - ADR

Silicon Motion Technology Corp.

Silicon Motion is experiencing significant momentum and investor interest, driven by its critical role in AI-focused enterprise storage and the successful rollout of advanced controller solutions. The community is actively discussing the stock's strong technical breakout, institutional accumulation, and the strategic positioning of its high-performance SSD and memory controller technology within the booming AI data center infrastructure market.

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is experiencing a massive surge following a robust earnings report that showcased significant revenue growth and positive guidance, fueling strong community sentiment regarding the company's long-term potential in AI-driven medical imaging. While some traders are capitalizing on the explosive upward momentum, others are actively debating whether this represents a sustained shift or another cyclical pump-and-dump susceptible to dilution and institutional selling.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is facing significant bearish sentiment as it trades near multi-year lows, with investors debating whether the current price represents a rare accumulation opportunity or a value trap. While the community remains deeply divided between those highlighting strong institutional utility and those frustrated by the coin's weak price action, the broader conversation is dominated by concerns over market manipulation and the need for a sustained recovery to restore confidence.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is gaining momentum as investors react to encouraging subcutaneous BRIUMVI data for myasthenia gravis, fueling optimism about expanding the drug's addressable market beyond multiple sclerosis. The community is actively debating the company's valuation, with many long-term shareholders anticipating a potential buyout and highlighting the asset as a strategic fit for larger pharmaceutical companies looking to capture significant market share.

NANO Nuclear Energy, Inc. is a microreactor and nuclear technology company, which provides supply energy services. Its products in technical development are ZEUS, a solid core battery reactor, and ODIN, a low-pressure coolant reactor. The company is founded by Jiang Yu in February, 2022 and is headquartered in New York, NY.

Nano Nuclear Energy Inc.

Nano Nuclear Energy is gaining significant traction as investors bet on the company's progress toward commercializing portable microreactors, specifically following a strategic partnership with Supermicro to power AI data centers. The community is actively debating the stock's speculative growth potential against its lack of current revenue, with many traders focusing on the company's NRC licensing progress and its recent acquisition of logistics assets to verticalize its supply chain.

Cantor Equity Partners II, Inc. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded on November 11, 2020 and is headquartered in New York, NY.

Cantor Equity Partners II Inc. - Ordinary Shares - Class A

Cantor Equity Partners II Inc

Cantor Equity Partners II is gaining attention as it nears its business combination with Securitize, a firm widely recognized as a market leader in real-world asset tokenization. The community is heavily focused on the stock's status as a pure-play infrastructure opportunity, frequently highlighting high-profile institutional backing from BlackRock and Morgan Stanley as key catalysts for future growth.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending as investors gear up for the upcoming quarterly earnings release and critical interim Phase 1 clinical data for its lead internal candidate, ABCL635. Community discussions are centered on strong institutional accumulation from major biotech-focused funds, while debate continues regarding the company's long-term platform potential versus its historical share price performance.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance continues to draw intense investor scrutiny as the market weighs the pending $110 billion merger with Warner Bros. Discovery against ongoing regulatory hurdles and recent antitrust lawsuits from several U.S. states. While shareholders express frustration over stagnant price action and the dilution associated with the deal, the community remains actively divided between those betting on long-term synergies and those deeply skeptical of management's ability to navigate current regulatory and debt headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


shbetdoctor

Shbet doctor